[Federal Register Volume 73, Number 34 (Wednesday, February 20, 2008)]
[Notices]
[Page 9356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-755]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--BioNanomatrix-Complete Genomics NIST ATP Joint 
Venture

    Notice is hereby given that, on January 10, 2008 pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), BioNanomatrix-Complete 
Genomics NIST ATP Joint Venture has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the partes and (2) the 
nature and objectives of the venture. The notifications were filed for 
the purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances.
    Pursuant to section 6(b) of the Act, the identities of the parties 
to the venture are: BioNanomatrix, Inc., Philadelphia, PA; and Complete 
Genomics, Inc., Mountain View, CA. The general area of planned activity 
for BioNanomatrix-Complete Genomics NIST ATP Joint Venture is to 
research the feasibility of sequencing the entire human genome in less 
than 8 hours for less than $100 using breakthrough technology called 
Linear Imaging Sequence Analysis (LISA) which requires the use of a 
novel sequence interrogation chemistry developed from CGI's ligation 
sequencing chemistry combined with a novel nanofluidic biochip adapted 
from BNM's nanoanalyzer technology.
    The activities of this venture project will be partially funded by 
an award from the Advanced Technology Program, National Institute of 
Standards and Technology, U.S. Department of Commerce under Award 
Number 70NANB7H7027.

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 08-755 Filed 2-19-08; 8:45 am]
BILLING CODE 4140-11-M